We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$58.3B
$58.3B $18.25 0.77%
TEVA icon
2
Teva Pharmaceuticals
TEVA
$43.1B
$43.1B $36.96 1.68%
HLN icon
3
Haleon
HLN
$40.4B
$40.4B $9.18 0.43%
ZTS icon
4
Zoetis
ZTS
$30.1B
$30.1B $72.91 0.07%
UTHR icon
5
United Therapeutics
UTHR
$21.4B
$21.4B $499.41 0.88%
VTRS icon
6
Viatris
VTRS
$19B
$19B $16.55 1.04%
NBIX icon
7
Neurocrine Biosciences
NBIX
$15.9B
$15.9B $156.78 0.13%
ELAN icon
8
Elanco Animal Health
ELAN
$11.5B
$11.5B $23.08 0.96%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$9.97B
$9.97B $11.97 2.22%
ALKS icon
10
Alkermes
ALKS
$7.72B
$7.72B $46.02 0.2%
LNTH icon
11
Lantheus
LNTH
$6.56B
$6.56B $100.39 0%
HIMS icon
12
Hims & Hers Health
HIMS
$6.37B
$6.37B $27.31 0.47%
LQDA icon
13
Liquidia Corp
LQDA
$6.07B
$6.07B $67.81 0.06%
KNSA icon
14
Kiniksa Pharmaceuticals
KNSA
$5.99B
$5.99B $76.72 0.31%
AMRX icon
15
Amneal Pharmaceuticals
AMRX
$5.89B
$5.89B $16.91 0.24%
INDV icon
16
Indivior Pharmaceuticals
INDV
$4.04B
$4.04B $34.27 0.7%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.55B
$3.55B $31.86 0.72%
RGC icon
18
Regencell Bioscience
RGC
$2.77B
$2.77B $5.60 0.71%
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.43B
$2.43B $41.70 0.02%
PBH icon
20
Prestige Consumer Healthcare
PBH
$2.24B
$2.24B $47.31 0.06%
HCM icon
21
HUTCHMED
HCM
$2.24B
$2.24B $12.86 1.98%
BHC icon
22
Bausch Health
BHC
$2.23B
$2.23B $5.97 1.65%
TRLV
23
Trulieve Cannabis Corp
TRLV
$2.17B
$2.17B $11.28 0.35%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$2.09B
$2.09B $8.16 1.57%
ALVO icon
25
Alvotech
ALVO
$1.9B
$1.9B $5.33 1.72%
1
2 3 4

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 81 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $336B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $58.3B, Teva Pharmaceuticals (TEVA) at $43.1B and Haleon (HLN) at $40.4B.

Among institutional investors, Trulieve Cannabis Corp (TRLV) drew the most net new fund positions in Q2 2026: 121 funds opened new positions, taking total fund holders up 119 (1,983%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.